世界の変形性関節症用再生医療市場2020年:企業別、地域別、種類・用途別

【英語タイトル】Global Regenerative Therapies for Osteoarthritis Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP07671)・商品コード:GIR20SP07671
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月23日(※2024年版があります。お問い合わせください)
・ページ数:102
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、変形性関節症用再生医療の世界市場を広く調査・分析し、今後の市場展望をまとめております。変形性関節症用再生医療の種類別市場規模(細胞治療、組織エンジニアリング、遺伝子治療)、用途別市場規模(病院、外来手術センター、整形外科クリニック、研究所)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Acelity、Athersys、Astellas Pharma、Mesoblast、Sanofi、Nuo Therapeutics、Cytori Therapeutics、Orgenesis、Organovo、Takeda
・地域別グローバル市場分析 2015年-2020年
・変形性関節症用再生医療の北米市場(アメリカ、カナダ、メキシコ)
・変形性関節症用再生医療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・変形性関節症用再生医療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・変形性関節症用再生医療の南米市場(ブラジル、アルゼンチン)
・変形性関節症用再生医療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:細胞治療、組織エンジニアリング、遺伝子治療
・用途別分析:病院、外来手術センター、整形外科クリニック、研究所
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The global Regenerative Therapies for Osteoarthritis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Regenerative Therapies for Osteoarthritis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Regenerative Therapies for Osteoarthritis market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Regenerative Therapies for Osteoarthritis market has been segmented into:
Cell Therapy
Tissue Engineering
Gene Therapy

By Application, Regenerative Therapies for Osteoarthritis has been segmented into:
Hospitals
Ambulatory Surgical Centers
Orthopaedic Clinics
Research Institutes

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Regenerative Therapies for Osteoarthritis market presented in the report. This section sheds light on the sales growth of different regional and country-level Regenerative Therapies for Osteoarthritis markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Regenerative Therapies for Osteoarthritis market.

The report offers in-depth assessment of the growth and other aspects of the Regenerative Therapies for Osteoarthritis market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Regenerative Therapies for Osteoarthritis Market Share Analysis
Regenerative Therapies for Osteoarthritis competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Regenerative Therapies for Osteoarthritis sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Regenerative Therapies for Osteoarthritis sales, revenue and market share for each player covered in this report.

The major players covered in Regenerative Therapies for Osteoarthritis are:
Acelity
Athersys
Astellas Pharma
Mesoblast
Sanofi
Nuo Therapeutics
Cytori Therapeutics
Orgenesis
Organovo
Takeda

【レポートの目次】

Table of Contents

1 Regenerative Therapies for Osteoarthritis Market Overview
1.1 Product Overview and Scope of Regenerative Therapies for Osteoarthritis
1.2 Classification of Regenerative Therapies for Osteoarthritis by Type
1.2.1 Global Regenerative Therapies for Osteoarthritis Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type in 2019
1.2.3 Cell Therapy
1.2.4 Tissue Engineering
1.2.5 Gene Therapy
1.3 Global Regenerative Therapies for Osteoarthritis Market by Application
1.3.1 Overview: Global Regenerative Therapies for Osteoarthritis Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Orthopaedic Clinics
1.3.5 Research Institutes
1.4 Global Regenerative Therapies for Osteoarthritis Market by Regions
1.4.1 Global Regenerative Therapies for Osteoarthritis Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Regenerative Therapies for Osteoarthritis (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Regenerative Therapies for Osteoarthritis Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Regenerative Therapies for Osteoarthritis Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Regenerative Therapies for Osteoarthritis Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Regenerative Therapies for Osteoarthritis Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Regenerative Therapies for Osteoarthritis Status and Prospect (2015-2025)
2 Company Profiles
2.1 Acelity
2.1.1 Acelity Details
2.1.2 Acelity Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Acelity SWOT Analysis
2.1.4 Acelity Product and Services
2.1.5 Acelity Regenerative Therapies for Osteoarthritis Revenue, Gross Margin and Market Share (2018-2019)
2.2 Athersys
2.2.1 Athersys Details
2.2.2 Athersys Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Athersys SWOT Analysis
2.2.4 Athersys Product and Services
2.2.5 Athersys Regenerative Therapies for Osteoarthritis Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astellas Pharma
2.3.1 Astellas Pharma Details
2.3.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astellas Pharma SWOT Analysis
2.3.4 Astellas Pharma Product and Services
2.3.5 Astellas Pharma Regenerative Therapies for Osteoarthritis Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mesoblast
2.4.1 Mesoblast Details
2.4.2 Mesoblast Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Mesoblast SWOT Analysis
2.4.4 Mesoblast Product and Services
2.4.5 Mesoblast Regenerative Therapies for Osteoarthritis Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Regenerative Therapies for Osteoarthritis Revenue, Gross Margin and Market Share (2018-2019)
2.6 Nuo Therapeutics
2.6.1 Nuo Therapeutics Details
2.6.2 Nuo Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Nuo Therapeutics SWOT Analysis
2.6.4 Nuo Therapeutics Product and Services
2.6.5 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cytori Therapeutics
2.7.1 Cytori Therapeutics Details
2.7.2 Cytori Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cytori Therapeutics SWOT Analysis
2.7.4 Cytori Therapeutics Product and Services
2.7.5 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Revenue, Gross Margin and Market Share (2018-2019)
2.8 Orgenesis
2.8.1 Orgenesis Details
2.8.2 Orgenesis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Orgenesis SWOT Analysis
2.8.4 Orgenesis Product and Services
2.8.5 Orgenesis Regenerative Therapies for Osteoarthritis Revenue, Gross Margin and Market Share (2018-2019)
2.9 Organovo
2.9.1 Organovo Details
2.9.2 Organovo Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Organovo SWOT Analysis
2.9.4 Organovo Product and Services
2.9.5 Organovo Regenerative Therapies for Osteoarthritis Revenue, Gross Margin and Market Share (2018-2019)
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Takeda SWOT Analysis
2.10.4 Takeda Product and Services
2.10.5 Takeda Regenerative Therapies for Osteoarthritis Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Regenerative Therapies for Osteoarthritis Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Regenerative Therapies for Osteoarthritis Players Market Share
3.2.2 Top 10 Regenerative Therapies for Osteoarthritis Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Regenerative Therapies for Osteoarthritis Revenue and Market Share by Regions
4.2 North America Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
4.3 Europe Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
4.5 South America Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
5 North America Regenerative Therapies for Osteoarthritis Revenue by Countries
5.1 North America Regenerative Therapies for Osteoarthritis Revenue by Countries (2015-2020)
5.2 USA Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
5.3 Canada Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
5.4 Mexico Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
6 Europe Regenerative Therapies for Osteoarthritis Revenue by Countries
6.1 Europe Regenerative Therapies for Osteoarthritis Revenue by Countries (2015-2020)
6.2 Germany Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
6.3 UK Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
6.4 France Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
6.5 Russia Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
6.6 Italy Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue by Countries
7.1 Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue by Countries (2015-2020)
7.2 China Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
7.3 Japan Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
7.4 Korea Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
7.5 India Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
8 South America Regenerative Therapies for Osteoarthritis Revenue by Countries
8.1 South America Regenerative Therapies for Osteoarthritis Revenue by Countries (2015-2020)
8.2 Brazil Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
8.3 Argentina Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Regenerative Therapies for Osteoarthritis by Countries
9.1 Middle East & Africa Regenerative Therapies for Osteoarthritis Revenue by Countries (2015-2020)
9.2 Saudi Arabia Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
9.3 UAE Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
9.4 Egypt Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
9.5 South Africa Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Regenerative Therapies for Osteoarthritis Revenue and Market Share by Type (2015-2020)
10.2 Global Regenerative Therapies for Osteoarthritis Market Forecast by Type (2019-2024)
10.3 Cell Therapy Revenue Growth Rate (2015-2025)
10.4 Tissue Engineering Revenue Growth Rate (2015-2025)
10.5 Gene Therapy Revenue Growth Rate (2015-2025)
11 Global Regenerative Therapies for Osteoarthritis Market Segment by Application
11.1 Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Application (2015-2020)
11.2 Regenerative Therapies for Osteoarthritis Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.5 Orthopaedic Clinics Revenue Growth (2015-2020)
11.6 Research Institutes Revenue Growth (2015-2020)
12 Global Regenerative Therapies for Osteoarthritis Market Size Forecast (2021-2025)
12.1 Global Regenerative Therapies for Osteoarthritis Market Size Forecast (2021-2025)
12.2 Global Regenerative Therapies for Osteoarthritis Market Forecast by Regions (2021-2025)
12.3 North America Regenerative Therapies for Osteoarthritis Revenue Market Forecast (2021-2025)
12.4 Europe Regenerative Therapies for Osteoarthritis Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue Market Forecast (2021-2025)
12.6 South America Regenerative Therapies for Osteoarthritis Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Regenerative Therapies for Osteoarthritis Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Regenerative Therapies for Osteoarthritis Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Regenerative Therapies for Osteoarthritis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Regenerative Therapies for Osteoarthritis Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Regenerative Therapies for Osteoarthritis Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Acelity Corporate Information, Location and Competitors
Table 6. Acelity Regenerative Therapies for Osteoarthritis Major Business
Table 7. Acelity Regenerative Therapies for Osteoarthritis Total Revenue (USD Million) (2017-2018)
Table 8. Acelity SWOT Analysis
Table 9. Acelity Regenerative Therapies for Osteoarthritis Product and Solutions
Table 10. Acelity Regenerative Therapies for Osteoarthritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Athersys Corporate Information, Location and Competitors
Table 12. Athersys Regenerative Therapies for Osteoarthritis Major Business
Table 13. Athersys Regenerative Therapies for Osteoarthritis Total Revenue (USD Million) (2018-2019)
Table 14. Athersys SWOT Analysis
Table 15. Athersys Regenerative Therapies for Osteoarthritis Product and Solutions
Table 16. Athersys Regenerative Therapies for Osteoarthritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Astellas Pharma Corporate Information, Location and Competitors
Table 18. Astellas Pharma Regenerative Therapies for Osteoarthritis Major Business
Table 19. Astellas Pharma Regenerative Therapies for Osteoarthritis Total Revenue (USD Million) (2017-2018)
Table 20. Astellas Pharma SWOT Analysis
Table 21. Astellas Pharma Regenerative Therapies for Osteoarthritis Product and Solutions
Table 22. Astellas Pharma Regenerative Therapies for Osteoarthritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Mesoblast Corporate Information, Location and Competitors
Table 24. Mesoblast Regenerative Therapies for Osteoarthritis Major Business
Table 25. Mesoblast Regenerative Therapies for Osteoarthritis Total Revenue (USD Million) (2017-2018)
Table 26. Mesoblast SWOT Analysis
Table 27. Mesoblast Regenerative Therapies for Osteoarthritis Product and Solutions
Table 28. Mesoblast Regenerative Therapies for Osteoarthritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sanofi Corporate Information, Location and Competitors
Table 30. Sanofi Regenerative Therapies for Osteoarthritis Major Business
Table 31. Sanofi Regenerative Therapies for Osteoarthritis Total Revenue (USD Million) (2017-2018)
Table 32. Sanofi SWOT Analysis
Table 33. Sanofi Regenerative Therapies for Osteoarthritis Product and Solutions
Table 34. Sanofi Regenerative Therapies for Osteoarthritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Nuo Therapeutics Corporate Information, Location and Competitors
Table 36. Nuo Therapeutics Regenerative Therapies for Osteoarthritis Major Business
Table 37. Nuo Therapeutics Regenerative Therapies for Osteoarthritis Total Revenue (USD Million) (2017-2018)
Table 38. Nuo Therapeutics SWOT Analysis
Table 39. Nuo Therapeutics Regenerative Therapies for Osteoarthritis Product and Solutions
Table 40. Nuo Therapeutics Regenerative Therapies for Osteoarthritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Cytori Therapeutics Corporate Information, Location and Competitors
Table 42. Cytori Therapeutics Regenerative Therapies for Osteoarthritis Major Business
Table 43. Cytori Therapeutics Regenerative Therapies for Osteoarthritis Total Revenue (USD Million) (2017-2018)
Table 44. Cytori Therapeutics SWOT Analysis
Table 45. Cytori Therapeutics Regenerative Therapies for Osteoarthritis Product and Solutions
Table 46. Cytori Therapeutics Regenerative Therapies for Osteoarthritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Orgenesis Corporate Information, Location and Competitors
Table 48. Orgenesis Regenerative Therapies for Osteoarthritis Major Business
Table 49. Orgenesis Regenerative Therapies for Osteoarthritis Total Revenue (USD Million) (2017-2018)
Table 50. Orgenesis SWOT Analysis
Table 51. Orgenesis Regenerative Therapies for Osteoarthritis Product and Solutions
Table 52. Orgenesis Regenerative Therapies for Osteoarthritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Organovo Corporate Information, Location and Competitors
Table 54. Organovo Regenerative Therapies for Osteoarthritis Major Business
Table 55. Organovo Regenerative Therapies for Osteoarthritis Total Revenue (USD Million) (2017-2018)
Table 56. Organovo SWOT Analysis
Table 57. Organovo Regenerative Therapies for Osteoarthritis Product and Solutions
Table 58. Organovo Regenerative Therapies for Osteoarthritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Takeda Corporate Information, Location and Competitors
Table 60. Takeda Regenerative Therapies for Osteoarthritis Major Business
Table 61. Takeda Regenerative Therapies for Osteoarthritis Total Revenue (USD Million) (2017-2018)
Table 62. Takeda SWOT Analysis
Table 63. Takeda Regenerative Therapies for Osteoarthritis Product and Solutions
Table 64. Takeda Regenerative Therapies for Osteoarthritis Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Regenerative Therapies for Osteoarthritis Revenue (Million USD) by Players (2015-2020)
Table 66. Global Regenerative Therapies for Osteoarthritis Revenue Share by Players (2015-2020)
Table 67. Global Regenerative Therapies for Osteoarthritis Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Regions (2015-2020)
Table 69. North America Regenerative Therapies for Osteoarthritis Revenue by Countries (2015-2020)
Table 70. North America Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries (2015-2020)
Table 71. Europe Regenerative Therapies for Osteoarthritis Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Regenerative Therapies for Osteoarthritis Revenue by Countries (2015-2020)
Table 74. South America Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries (2015-2020)
Table 77. Global Regenerative Therapies for Osteoarthritis Revenue (Million USD) by Type (2015-2020)
Table 78. Global Regenerative Therapies for Osteoarthritis Revenue Share by Type (2015-2020)
Table 79. Global Regenerative Therapies for Osteoarthritis Revenue Forecast by Type (2021-2025)
Table 80. Global Regenerative Therapies for Osteoarthritis Revenue by Application (2015-2020)
Table 81. Global Regenerative Therapies for Osteoarthritis Revenue Share by Application (2015-2020)
Table 82. Global Regenerative Therapies for Osteoarthritis Revenue Forecast by Application (2021-2025)
Table 83. Global Regenerative Therapies for Osteoarthritis Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Regenerative Therapies for Osteoarthritis Picture
Figure 2. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type in 2019
Figure 3. Cell Therapy Picture
Figure 4. Tissue Engineering Picture
Figure 5. Gene Therapy Picture
Figure 6. Regenerative Therapies for Osteoarthritis Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Ambulatory Surgical Centers Picture
Figure 9. Orthopaedic Clinics Picture
Figure 10. Research Institutes Picture
Figure 11. Global Regenerative Therapies for Osteoarthritis Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Regenerative Therapies for Osteoarthritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Regenerative Therapies for Osteoarthritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Regenerative Therapies for Osteoarthritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Regenerative Therapies for Osteoarthritis Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Regenerative Therapies for Osteoarthritis Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Regenerative Therapies for Osteoarthritis Revenue Market Share in 2019
Figure 20. Global Top 10 Players Regenerative Therapies for Osteoarthritis Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Regenerative Therapies for Osteoarthritis Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Regions (2015-2020)
Figure 24. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Regions in 2018
Figure 25. North America Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 26. Europe Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 28. South America Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 30. North America Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries (2015-2020)
Figure 31. North America Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries in 2019
Figure 32. USA Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 33. Canada Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 35. Europe Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries in 2019
Figure 37. Germany Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 38. UK Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 39. France Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 40. Russia Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 41. Italy Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries in 2019
Figure 44. China Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 45. Japan Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 46. Korea Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 47. India Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 49. South America Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries (2015-2020)
Figure 50. South America Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries in 2019
Figure 51. Brazil Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 56. UAE Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Regenerative Therapies for Osteoarthritis Revenue and Growth Rate (2015-2020)
Figure 59. Global Regenerative Therapies for Osteoarthritis Revenue Share by Type (2015-2020)
Figure 60. Global Regenerative Therapies for Osteoarthritis Revenue Share by Type in 2019
Figure 61. Global Regenerative Therapies for Osteoarthritis Market Share Forecast by Type (2021-2025)
Figure 62. Global Cell Therapy Revenue Growth Rate (2015-2020)
Figure 63. Global Tissue Engineering Revenue Growth Rate (2015-2020)
Figure 64. Global Gene Therapy Revenue Growth Rate (2015-2020)
Figure 65. Global Regenerative Therapies for Osteoarthritis Revenue Share by Application (2015-2020)
Figure 66. Global Regenerative Therapies for Osteoarthritis Revenue Share by Application in 2019
Figure 67. Global Regenerative Therapies for Osteoarthritis Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 69. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 70. Global Orthopaedic Clinics Revenue Growth Rate (2015-2020)
Figure 71. Global Research Institutes Revenue Growth Rate (2015-2020)
Figure 72. Global Regenerative Therapies for Osteoarthritis Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Regenerative Therapies for Osteoarthritis Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Regenerative Therapies for Osteoarthritis Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Regenerative Therapies for Osteoarthritis Revenue Market Forecast (2021-2025)
Figure 76. Europe Regenerative Therapies for Osteoarthritis Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue Market Forecast (2021-2025)
Figure 78. South America Regenerative Therapies for Osteoarthritis Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Acelity、Athersys、Astellas Pharma、Mesoblast、Sanofi、Nuo Therapeutics、Cytori Therapeutics、Orgenesis、Organovo、Takeda

★調査レポート[世界の変形性関節症用再生医療市場2020年:企業別、地域別、種類・用途別] (コード:GIR20SP07671)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の変形性関節症用再生医療市場2020年:企業別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆